Fed Holds But Signals Hawkish Path Ahead, Treasury Yields Rise: The Week In The Markets
The Federal Open Market Committee meeting dominated the markets this week, with the Fed deciding to leave rates…
Tenaya Therapeutics To Present Data For TN-301 And TN-201 At Upcoming Medical Conferences
TN-301 First-in-Human Phase 1 Clinical Trial Results and Preclinical Combination Data to be Presented at Heart Failure Society of America Annual Scientific MeetingTN-201 Interim Seroprevalence Study Data and Phase 1b
Veracyte Announces Novel Afirma-Based Findings That Advance Molecular Understanding Of Thyroid Cancer To Be Presented At The 2023 ATA Annual Meeting
- Three abstracts demonstrate new insights that can be derived from whole-transcriptome-based thyroid cancer molecular profiles -Veracyte, Inc. (NASDAQ:VCYT) today announced that three posters showcasing new data from
Microsoft AI Announcement Drives Stock Higher: How Copilot Will Rollout
Microsoft Corp (NASDAQ: MSFT) made an announcement Thursday regarding broad availability of its new artificial intelligence companion, Copilot.
BioMarin To Present Data Showing Long-Term Benefit Of VOXZOGO On Growth In Children With Achondroplasia At 2023 European Society For Paediatric Endocrinology Meeting
Label Expansion Decisions Expected from U.S. and European Regulatory Authorities in Q4SAN RAFAEL, Calif., Sept. 21, 2023 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), a global biotechnology company
Biodexa To Present Recruitment And Treatment Update In Phase 1 Study Of MTX-110 In Patients With Recurrent Glioblastoma At 2023 Annual European Association Of Neuro-Oncology Meeting
Biodexa to Present Recruitment and Treatment Update in Phase 1 Study of MTX-110 (MAGIC-G1 Study) in Patients with Recurrent Glioblastoma at
2023 Annual European Association of Neuro-Oncology Meeting (EANO)
Biodexa
Purple Biotech To Present New CM24 Pancreatic Cancer Biomarker Data At AACR Special Conference On September 28, 2023
Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that harness the power of the tumor microenvironment to overcome tumor immune
What’s Going On With Intel Stock?
Intel Corp (NASDAQ: INTC) shares are trading narrowly lower Wednesday after falling more than 4% on Tuesday.
Zoom X Running On Vuzix Smart Glasses Highlights 5G Solutions At Deutsche Telekom’s Digital X 2023 Exhibition
Vuzix® Corporation (NASDAQ:VUZI), ("Vuzix" or, the "Company"), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, announced that the Company will be broadly showcasing
Assembly Biosciences To Highlight Pipeline Progress In HBV And HDV At The 2023 International HBV Meeting
-- Two oral presentations and one poster will feature new data from the Company's hepatitis B/hepatitis D entry inhibitor, capsid assembly modulator ABI-4334, and interferon-alpha receptor agonist programs --
SOUTH